~~<i id='43BF7B33D4'><strike id='43BF7B33D4'><tt id='43BF7B33D4'><pre id='43BF7B33D4'></pre></tt></strike></i>~~

Home» leisure time» comprehensive

comprehensive

author：explore 2025-10-02 14:55:46 Page View：98966

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby
Next article： Hollywood unions extend contract negotiations for actors

knowledge

23andMe had bad news about my health. I wish a person had delivered it

ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Howdocancerdrugswork?Whatmakesbiotechstocksgoup?Andwhyareventurecapitalistssooptimistic?Wecoverallth

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

ACA's risk program benefits Blue Cross Blue Shield insurers

AdobeAprogramthatundergirdstheAffordableCareAct’shealthinsurancemarketplacescontinuestobolsterthebal